avrg: GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Hnf4g
|
ENSMUSG00000017688.8 | hepatocyte nuclear factor 4, gamma |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Hnf4g | mm10_v2_chr3_+_3634145_3634161 | -0.51 | 1.7e-03 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr19_+_39287074 | 28.10 |
ENSMUST00000003137.8
|
Cyp2c29
|
cytochrome P450, family 2, subfamily c, polypeptide 29 |
chr17_-_46438471 | 24.97 |
ENSMUST00000087012.5
|
Slc22a7
|
solute carrier family 22 (organic anion transporter), member 7 |
chr19_+_39007019 | 17.73 |
ENSMUST00000025966.4
|
Cyp2c55
|
cytochrome P450, family 2, subfamily c, polypeptide 55 |
chr5_+_146079254 | 17.18 |
ENSMUST00000035571.8
|
Cyp3a59
|
cytochrome P450, family 3, subfamily a, polypeptide 59 |
chr5_-_87337165 | 17.00 |
ENSMUST00000031195.2
|
Ugt2a3
|
UDP glucuronosyltransferase 2 family, polypeptide A3 |
chr16_-_18089022 | 16.89 |
ENSMUST00000132241.1
ENSMUST00000139861.1 ENSMUST00000003620.5 |
Prodh
|
proline dehydrogenase |
chr9_-_46235631 | 16.84 |
ENSMUST00000118649.1
|
Apoc3
|
apolipoprotein C-III |
chr9_-_46235260 | 14.81 |
ENSMUST00000121916.1
ENSMUST00000034586.2 |
Apoc3
|
apolipoprotein C-III |
chr15_-_82764176 | 14.37 |
ENSMUST00000055721.4
|
Cyp2d40
|
cytochrome P450, family 2, subfamily d, polypeptide 40 |
chr17_-_32917048 | 13.37 |
ENSMUST00000054174.7
|
Cyp4f14
|
cytochrome P450, family 4, subfamily f, polypeptide 14 |
chr11_-_5915124 | 12.75 |
ENSMUST00000109823.2
ENSMUST00000109822.1 |
Gck
|
glucokinase |
chr4_-_62087261 | 12.70 |
ENSMUST00000107488.3
ENSMUST00000107472.1 ENSMUST00000084531.4 |
Mup3
|
major urinary protein 3 |
chr7_-_99695628 | 12.50 |
ENSMUST00000145381.1
|
Slco2b1
|
solute carrier organic anion transporter family, member 2b1 |
chr10_+_127801145 | 12.31 |
ENSMUST00000071646.1
|
Rdh16
|
retinol dehydrogenase 16 |
chr7_+_46751832 | 12.09 |
ENSMUST00000075982.2
|
Saa2
|
serum amyloid A 2 |
chr2_+_173153048 | 11.62 |
ENSMUST00000029017.5
|
Pck1
|
phosphoenolpyruvate carboxykinase 1, cytosolic |
chr4_+_115411624 | 11.39 |
ENSMUST00000094887.3
|
Cyp4a12b
|
cytochrome P450, family 4, subfamily a, polypeptide 12B |
chr1_+_74713551 | 11.22 |
ENSMUST00000027356.5
|
Cyp27a1
|
cytochrome P450, family 27, subfamily a, polypeptide 1 |
chr7_-_99695572 | 11.07 |
ENSMUST00000137914.1
|
Slco2b1
|
solute carrier organic anion transporter family, member 2b1 |
chr16_-_18413452 | 10.98 |
ENSMUST00000165430.1
ENSMUST00000147720.1 |
Comt
|
catechol-O-methyltransferase |
chr19_-_8405060 | 10.83 |
ENSMUST00000064507.5
ENSMUST00000120540.1 ENSMUST00000096269.4 |
Slc22a30
|
solute carrier family 22, member 30 |
chr19_+_39992424 | 10.74 |
ENSMUST00000049178.2
|
Cyp2c37
|
cytochrome P450, family 2. subfamily c, polypeptide 37 |
chr4_+_63362443 | 10.71 |
ENSMUST00000075341.3
|
Orm2
|
orosomucoid 2 |
chr8_+_104733997 | 10.59 |
ENSMUST00000034346.8
ENSMUST00000164182.2 |
Ces2a
|
carboxylesterase 2A |
chr17_-_32917320 | 10.50 |
ENSMUST00000179434.1
|
Cyp4f14
|
cytochrome P450, family 4, subfamily f, polypeptide 14 |
chr19_-_39463067 | 10.29 |
ENSMUST00000035488.2
|
Cyp2c38
|
cytochrome P450, family 2, subfamily c, polypeptide 38 |
chr4_-_60139857 | 10.28 |
ENSMUST00000107490.4
ENSMUST00000074700.2 |
Mup2
|
major urinary protein 2 |
chr15_+_10223974 | 10.28 |
ENSMUST00000128450.1
ENSMUST00000148257.1 ENSMUST00000128921.1 |
Prlr
|
prolactin receptor |
chr10_-_24927444 | 10.10 |
ENSMUST00000020161.8
|
Arg1
|
arginase, liver |
chr8_-_93079965 | 9.60 |
ENSMUST00000109582.1
|
Ces1b
|
carboxylesterase 1B |
chr15_+_82555087 | 9.60 |
ENSMUST00000068861.6
|
Cyp2d12
|
cytochrome P450, family 2, subfamily d, polypeptide 12 |
chr5_-_113081579 | 9.43 |
ENSMUST00000131708.1
ENSMUST00000117143.1 ENSMUST00000119627.1 |
Crybb3
|
crystallin, beta B3 |
chr10_+_40629987 | 9.40 |
ENSMUST00000019977.7
|
Ddo
|
D-aspartate oxidase |
chr9_+_44673227 | 9.32 |
ENSMUST00000034609.4
ENSMUST00000071219.5 |
Treh
|
trehalase (brush-border membrane glycoprotein) |
chr8_-_94696223 | 9.21 |
ENSMUST00000034227.4
|
Pllp
|
plasma membrane proteolipid |
chr4_-_61674094 | 8.96 |
ENSMUST00000098040.3
|
Mup18
|
major urinary protein 18 |
chr8_-_109579056 | 8.79 |
ENSMUST00000074898.6
|
Hp
|
haptoglobin |
chr4_-_115496129 | 8.74 |
ENSMUST00000030487.2
|
Cyp4a14
|
cytochrome P450, family 4, subfamily a, polypeptide 14 |
chr16_+_91269759 | 8.63 |
ENSMUST00000056882.5
|
Olig1
|
oligodendrocyte transcription factor 1 |
chr5_-_145879857 | 8.57 |
ENSMUST00000035918.7
|
Cyp3a11
|
cytochrome P450, family 3, subfamily a, polypeptide 11 |
chr7_-_141276729 | 8.55 |
ENSMUST00000167263.1
ENSMUST00000080654.5 |
Cdhr5
|
cadherin-related family member 5 |
chr2_+_102706356 | 8.47 |
ENSMUST00000123759.1
ENSMUST00000111212.1 ENSMUST00000005220.4 |
Slc1a2
|
solute carrier family 1 (glial high affinity glutamate transporter), member 2 |
chr11_+_115462464 | 8.46 |
ENSMUST00000106532.3
ENSMUST00000092445.5 ENSMUST00000153466.1 |
Slc16a5
|
solute carrier family 16 (monocarboxylic acid transporters), member 5 |
chr11_-_5950018 | 8.28 |
ENSMUST00000102920.3
|
Gck
|
glucokinase |
chr7_-_99695809 | 8.11 |
ENSMUST00000107086.2
|
Slco2b1
|
solute carrier organic anion transporter family, member 2b1 |
chr4_-_60222580 | 8.01 |
ENSMUST00000095058.4
ENSMUST00000163931.1 |
Mup8
|
major urinary protein 8 |
chr4_-_59960659 | 7.98 |
ENSMUST00000075973.2
|
Mup4
|
major urinary protein 4 |
chr7_-_105600103 | 7.92 |
ENSMUST00000033185.8
|
Hpx
|
hemopexin |
chr19_+_37697792 | 7.80 |
ENSMUST00000025946.5
|
Cyp26a1
|
cytochrome P450, family 26, subfamily a, polypeptide 1 |
chr11_-_115187321 | 7.61 |
ENSMUST00000103038.1
ENSMUST00000103039.1 ENSMUST00000103040.4 |
Nat9
|
N-acetyltransferase 9 (GCN5-related, putative) |
chr4_-_122961173 | 7.58 |
ENSMUST00000030408.5
ENSMUST00000127047.1 |
Mfsd2a
|
major facilitator superfamily domain containing 2A |
chr3_-_121815212 | 7.55 |
ENSMUST00000029770.5
|
Abcd3
|
ATP-binding cassette, sub-family D (ALD), member 3 |
chr19_+_39510844 | 7.47 |
ENSMUST00000025968.4
|
Cyp2c39
|
cytochrome P450, family 2, subfamily c, polypeptide 39 |
chr4_+_63344548 | 7.36 |
ENSMUST00000030044.2
|
Orm1
|
orosomucoid 1 |
chr11_+_72435511 | 7.32 |
ENSMUST00000076443.3
|
Ggt6
|
gamma-glutamyltransferase 6 |
chr8_-_123236198 | 7.31 |
ENSMUST00000166768.1
ENSMUST00000098327.1 |
Spata2l
|
spermatogenesis associated 2-like |
chr19_+_12633507 | 7.30 |
ENSMUST00000119960.1
|
Glyat
|
glycine-N-acyltransferase |
chr8_+_105048592 | 7.26 |
ENSMUST00000093222.5
ENSMUST00000093223.3 |
Ces3a
|
carboxylesterase 3A |
chr7_-_97417730 | 7.23 |
ENSMUST00000043077.7
|
Thrsp
|
thyroid hormone responsive |
chr9_-_57683644 | 7.18 |
ENSMUST00000034860.3
|
Cyp1a2
|
cytochrome P450, family 1, subfamily a, polypeptide 2 |
chr11_+_70054334 | 7.16 |
ENSMUST00000018699.6
ENSMUST00000108585.2 |
Asgr1
|
asialoglycoprotein receptor 1 |
chr3_-_113574242 | 7.16 |
ENSMUST00000142505.2
|
Amy1
|
amylase 1, salivary |
chr15_+_82452372 | 7.15 |
ENSMUST00000089129.5
|
Cyp2d9
|
cytochrome P450, family 2, subfamily d, polypeptide 9 |
chr1_+_166254095 | 7.05 |
ENSMUST00000111416.1
|
Ildr2
|
immunoglobulin-like domain containing receptor 2 |
chr10_+_127866457 | 7.00 |
ENSMUST00000092058.3
|
BC089597
|
cDNA sequence BC089597 |
chr11_+_72435565 | 6.98 |
ENSMUST00000100903.2
|
Ggt6
|
gamma-glutamyltransferase 6 |
chr6_+_141629499 | 6.93 |
ENSMUST00000042812.6
|
Slco1b2
|
solute carrier organic anion transporter family, member 1b2 |
chr1_-_162984519 | 6.87 |
ENSMUST00000028010.7
|
Fmo3
|
flavin containing monooxygenase 3 |
chr11_+_72435534 | 6.85 |
ENSMUST00000108499.1
|
Ggt6
|
gamma-glutamyltransferase 6 |
chr12_-_103457195 | 6.81 |
ENSMUST00000044687.6
|
Ifi27l2b
|
interferon, alpha-inducible protein 27 like 2B |
chr3_+_63295815 | 6.67 |
ENSMUST00000029400.1
|
Mme
|
membrane metallo endopeptidase |
chr1_-_162866502 | 6.65 |
ENSMUST00000046049.7
|
Fmo1
|
flavin containing monooxygenase 1 |
chr13_-_55426769 | 6.62 |
ENSMUST00000170921.1
|
F12
|
coagulation factor XII (Hageman factor) |
chr10_+_127759780 | 6.62 |
ENSMUST00000128247.1
|
RP23-386P10.11
|
Protein Rdh9 |
chr11_+_76679757 | 6.59 |
ENSMUST00000062024.2
|
Tusc5
|
tumor suppressor candidate 5 |
chr10_+_63024315 | 6.56 |
ENSMUST00000124784.1
|
Pbld2
|
phenazine biosynthesis-like protein domain containing 2 |
chr17_-_56117265 | 6.49 |
ENSMUST00000113072.2
|
Plin5
|
perilipin 5 |
chr13_-_55426783 | 6.48 |
ENSMUST00000021948.8
|
F12
|
coagulation factor XII (Hageman factor) |
chr9_+_46268601 | 6.48 |
ENSMUST00000121598.1
|
Apoa5
|
apolipoprotein A-V |
chrX_+_59999436 | 6.47 |
ENSMUST00000033477.4
|
F9
|
coagulation factor IX |
chr2_+_58755177 | 6.41 |
ENSMUST00000102755.3
|
Upp2
|
uridine phosphorylase 2 |
chr1_-_91413163 | 6.40 |
ENSMUST00000086851.1
|
Hes6
|
hairy and enhancer of split 6 |
chr10_-_127888688 | 6.32 |
ENSMUST00000047199.4
|
Rdh7
|
retinol dehydrogenase 7 |
chr1_-_162898665 | 6.30 |
ENSMUST00000111510.1
ENSMUST00000045902.6 |
Fmo2
|
flavin containing monooxygenase 2 |
chr15_-_82620907 | 6.28 |
ENSMUST00000109515.1
|
Cyp2d34
|
cytochrome P450, family 2, subfamily d, polypeptide 34 |
chr6_-_85933379 | 6.28 |
ENSMUST00000162660.1
|
Nat8b
|
N-acetyltransferase 8B |
chr4_-_108118504 | 6.24 |
ENSMUST00000149106.1
|
Scp2
|
sterol carrier protein 2, liver |
chr19_-_8218832 | 6.24 |
ENSMUST00000113298.2
|
Slc22a29
|
solute carrier family 22. member 29 |
chr10_-_127370535 | 6.21 |
ENSMUST00000026472.8
|
Inhbc
|
inhibin beta-C |
chr4_-_138326234 | 6.18 |
ENSMUST00000105817.3
ENSMUST00000030536.6 |
Pink1
|
PTEN induced putative kinase 1 |
chr3_-_113574758 | 6.16 |
ENSMUST00000106540.1
|
Amy1
|
amylase 1, salivary |
chr12_-_103773592 | 6.11 |
ENSMUST00000078869.5
|
Serpina1d
|
serine (or cysteine) peptidase inhibitor, clade A, member 1D |
chr19_+_3986564 | 6.09 |
ENSMUST00000054030.7
|
Acy3
|
aspartoacylase (aminoacylase) 3 |
chr2_-_25461094 | 6.03 |
ENSMUST00000114261.2
|
BC029214
|
cDNA sequence BC029214 |
chr19_+_12633303 | 6.03 |
ENSMUST00000044976.5
|
Glyat
|
glycine-N-acyltransferase |
chr10_+_128254131 | 5.97 |
ENSMUST00000060782.3
|
Apon
|
apolipoprotein N |
chr9_-_121916288 | 5.90 |
ENSMUST00000062474.4
|
Cyp8b1
|
cytochrome P450, family 8, subfamily b, polypeptide 1 |
chr4_+_115299046 | 5.86 |
ENSMUST00000084343.3
|
Cyp4a12a
|
cytochrome P450, family 4, subfamily a, polypeptide 12a |
chr2_-_25500613 | 5.83 |
ENSMUST00000040042.4
|
C8g
|
complement component 8, gamma polypeptide |
chr19_-_8131982 | 5.80 |
ENSMUST00000065651.4
|
Slc22a28
|
solute carrier family 22, member 28 |
chr1_-_121327734 | 5.69 |
ENSMUST00000160968.1
ENSMUST00000162582.1 |
Insig2
|
insulin induced gene 2 |
chr13_+_23870259 | 5.68 |
ENSMUST00000110413.1
|
Slc17a1
|
solute carrier family 17 (sodium phosphate), member 1 |
chr5_-_120503593 | 5.67 |
ENSMUST00000031597.6
|
Plbd2
|
phospholipase B domain containing 2 |
chr9_-_119157055 | 5.62 |
ENSMUST00000010795.4
|
Acaa1b
|
acetyl-Coenzyme A acyltransferase 1B |
chr4_-_114908892 | 5.62 |
ENSMUST00000068654.3
|
Foxd2
|
forkhead box D2 |
chr15_-_86033777 | 5.58 |
ENSMUST00000016172.7
|
Celsr1
|
cadherin, EGF LAG seven-pass G-type receptor 1 (flamingo homolog, Drosophila) |
chrX_+_139800795 | 5.55 |
ENSMUST00000054889.3
|
Cldn2
|
claudin 2 |
chr7_+_26835305 | 5.53 |
ENSMUST00000005685.8
|
Cyp2a5
|
cytochrome P450, family 2, subfamily a, polypeptide 5 |
chr11_-_77519186 | 5.50 |
ENSMUST00000100807.2
|
Gm10392
|
predicted gene 10392 |
chr9_+_46240696 | 5.49 |
ENSMUST00000034585.6
|
Apoa4
|
apolipoprotein A-IV |
chr7_-_72306595 | 5.47 |
ENSMUST00000079323.5
|
Mctp2
|
multiple C2 domains, transmembrane 2 |
chr7_-_140154712 | 5.39 |
ENSMUST00000059241.7
|
Sprn
|
shadow of prion protein |
chr1_+_171214013 | 5.39 |
ENSMUST00000111328.1
|
Nr1i3
|
nuclear receptor subfamily 1, group I, member 3 |
chr7_+_143473736 | 5.38 |
ENSMUST00000052348.5
|
Slc22a18
|
solute carrier family 22 (organic cation transporter), member 18 |
chr1_-_180195981 | 5.37 |
ENSMUST00000027766.6
ENSMUST00000161814.1 |
Adck3
|
aarF domain containing kinase 3 |
chr3_-_157925056 | 5.34 |
ENSMUST00000118539.1
|
Cth
|
cystathionase (cystathionine gamma-lyase) |
chr16_+_26581704 | 5.29 |
ENSMUST00000096129.2
ENSMUST00000166294.2 ENSMUST00000174202.1 ENSMUST00000023156.6 |
Il1rap
|
interleukin 1 receptor accessory protein |
chr8_-_25038875 | 5.22 |
ENSMUST00000084031.4
|
Htra4
|
HtrA serine peptidase 4 |
chr6_-_85832082 | 5.22 |
ENSMUST00000032073.6
|
Nat8
|
N-acetyltransferase 8 (GCN5-related, putative) |
chr16_-_97922582 | 5.20 |
ENSMUST00000170757.1
|
C2cd2
|
C2 calcium-dependent domain containing 2 |
chr7_+_51880312 | 5.19 |
ENSMUST00000145049.1
|
Gas2
|
growth arrest specific 2 |
chr8_-_93197799 | 5.15 |
ENSMUST00000034172.7
|
Ces1d
|
carboxylesterase 1D |
chr15_+_75449457 | 5.12 |
ENSMUST00000177479.1
|
Gm20654
|
predicted gene 20654 |
chr11_-_113708952 | 5.11 |
ENSMUST00000106617.1
|
Cpsf4l
|
cleavage and polyadenylation specific factor 4-like |
chr10_-_41587753 | 5.07 |
ENSMUST00000160751.1
|
Ccdc162
|
coiled-coil domain containing 162 |
chr2_+_32599698 | 5.02 |
ENSMUST00000131229.1
ENSMUST00000140983.1 ENSMUST00000095045.2 |
St6galnac6
|
ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 6 |
chr17_+_32685655 | 5.00 |
ENSMUST00000008801.6
|
Cyp4f15
|
cytochrome P450, family 4, subfamily f, polypeptide 15 |
chr2_-_25501717 | 4.98 |
ENSMUST00000015227.3
|
C8g
|
complement component 8, gamma polypeptide |
chr18_-_32139570 | 4.98 |
ENSMUST00000171765.1
|
Proc
|
protein C |
chr17_+_27018005 | 4.98 |
ENSMUST00000122106.1
|
Ggnbp1
|
gametogenetin binding protein 1 |
chr1_-_136260873 | 4.95 |
ENSMUST00000086395.5
|
Gpr25
|
G protein-coupled receptor 25 |
chr9_-_103288224 | 4.94 |
ENSMUST00000123530.1
|
1300017J02Rik
|
RIKEN cDNA 1300017J02 gene |
chr7_-_12998140 | 4.92 |
ENSMUST00000032539.7
|
Slc27a5
|
solute carrier family 27 (fatty acid transporter), member 5 |
chr5_+_127632238 | 4.91 |
ENSMUST00000118139.1
|
Glt1d1
|
glycosyltransferase 1 domain containing 1 |
chr16_+_22920222 | 4.87 |
ENSMUST00000023587.4
ENSMUST00000116625.2 |
Fetub
|
fetuin beta |
chr9_-_103288290 | 4.86 |
ENSMUST00000035163.3
|
1300017J02Rik
|
RIKEN cDNA 1300017J02 gene |
chr17_-_31636631 | 4.84 |
ENSMUST00000135425.1
ENSMUST00000151718.1 ENSMUST00000155814.1 |
Cbs
|
cystathionine beta-synthase |
chr18_-_61911783 | 4.84 |
ENSMUST00000049378.8
ENSMUST00000166783.1 |
Ablim3
|
actin binding LIM protein family, member 3 |
chr10_+_63024512 | 4.83 |
ENSMUST00000020262.4
|
Pbld2
|
phenazine biosynthesis-like protein domain containing 2 |
chr6_+_124493101 | 4.82 |
ENSMUST00000049124.9
|
C1rl
|
complement component 1, r subcomponent-like |
chrX_-_100412587 | 4.78 |
ENSMUST00000033567.8
|
Awat2
|
acyl-CoA wax alcohol acyltransferase 2 |
chr17_+_47436731 | 4.77 |
ENSMUST00000150819.2
|
AI661453
|
expressed sequence AI661453 |
chr7_-_12998172 | 4.77 |
ENSMUST00000120903.1
|
Slc27a5
|
solute carrier family 27 (fatty acid transporter), member 5 |
chr1_+_171213969 | 4.76 |
ENSMUST00000005820.4
ENSMUST00000075469.5 ENSMUST00000155126.1 |
Nr1i3
|
nuclear receptor subfamily 1, group I, member 3 |
chr15_-_82394022 | 4.73 |
ENSMUST00000170255.1
|
Cyp2d11
|
cytochrome P450, family 2, subfamily d, polypeptide 11 |
chr7_-_126676357 | 4.71 |
ENSMUST00000106371.1
ENSMUST00000106372.3 ENSMUST00000155419.1 |
Sult1a1
|
sulfotransferase family 1A, phenol-preferring, member 1 |
chr8_+_45658666 | 4.70 |
ENSMUST00000134675.1
ENSMUST00000139869.1 ENSMUST00000126067.1 |
Sorbs2
|
sorbin and SH3 domain containing 2 |
chr2_+_58754910 | 4.69 |
ENSMUST00000059102.6
|
Upp2
|
uridine phosphorylase 2 |
chr7_+_119617804 | 4.68 |
ENSMUST00000135683.1
|
Acsm1
|
acyl-CoA synthetase medium-chain family member 1 |
chr14_-_57104693 | 4.64 |
ENSMUST00000055698.7
|
Gjb2
|
gap junction protein, beta 2 |
chr10_+_18845071 | 4.60 |
ENSMUST00000019998.7
|
Perp
|
PERP, TP53 apoptosis effector |
chr17_+_35470083 | 4.59 |
ENSMUST00000174525.1
ENSMUST00000068291.6 |
H2-Q10
|
histocompatibility 2, Q region locus 10 |
chr18_-_38211957 | 4.58 |
ENSMUST00000159405.1
ENSMUST00000160721.1 |
Pcdh1
|
protocadherin 1 |
chr7_-_84151868 | 4.56 |
ENSMUST00000117085.1
|
Abhd17c
|
abhydrolase domain containing 17C |
chr13_-_19307551 | 4.54 |
ENSMUST00000103561.1
|
Tcrg-C2
|
T-cell receptor gamma, constant 2 |
chr4_+_141368116 | 4.52 |
ENSMUST00000006380.4
|
Fam131c
|
family with sequence similarity 131, member C |
chr9_-_86695897 | 4.51 |
ENSMUST00000034989.8
|
Me1
|
malic enzyme 1, NADP(+)-dependent, cytosolic |
chr5_-_45450121 | 4.50 |
ENSMUST00000127562.1
|
Qdpr
|
quinoid dihydropteridine reductase |
chr2_+_25395866 | 4.48 |
ENSMUST00000028328.2
|
Entpd2
|
ectonucleoside triphosphate diphosphohydrolase 2 |
chr7_-_30973399 | 4.46 |
ENSMUST00000098553.4
ENSMUST00000147431.1 |
Lsr
|
lipolysis stimulated lipoprotein receptor |
chr13_-_93637961 | 4.45 |
ENSMUST00000099309.4
|
Bhmt
|
betaine-homocysteine methyltransferase |
chr17_-_56117577 | 4.44 |
ENSMUST00000019808.5
|
Plin5
|
perilipin 5 |
chr6_-_129237948 | 4.39 |
ENSMUST00000181238.1
ENSMUST00000180379.1 |
2310001H17Rik
|
RIKEN cDNA 2310001H17 gene |
chr7_-_97579382 | 4.39 |
ENSMUST00000151840.1
ENSMUST00000135998.1 ENSMUST00000144858.1 ENSMUST00000146605.1 ENSMUST00000072725.5 ENSMUST00000138060.1 ENSMUST00000154853.1 ENSMUST00000136757.1 ENSMUST00000124552.1 |
Aamdc
|
adipogenesis associated Mth938 domain containing |
chr7_-_126676428 | 4.37 |
ENSMUST00000106373.1
|
Sult1a1
|
sulfotransferase family 1A, phenol-preferring, member 1 |
chr5_-_77115145 | 4.34 |
ENSMUST00000081964.5
|
Hopx
|
HOP homeobox |
chr19_-_40187277 | 4.34 |
ENSMUST00000051846.6
|
Cyp2c70
|
cytochrome P450, family 2, subfamily c, polypeptide 70 |
chr2_+_27079371 | 4.30 |
ENSMUST00000091233.6
|
Adamtsl2
|
ADAMTS-like 2 |
chr7_-_132576372 | 4.27 |
ENSMUST00000084500.6
|
Oat
|
ornithine aminotransferase |
chr6_-_85915653 | 4.27 |
ENSMUST00000161198.2
|
Cml1
|
camello-like 1 |
chr2_-_25470031 | 4.25 |
ENSMUST00000114251.1
|
Ptgds
|
prostaglandin D2 synthase (brain) |
chr17_-_34862473 | 4.23 |
ENSMUST00000025229.4
ENSMUST00000176203.2 ENSMUST00000128767.1 |
Cfb
|
complement factor B |
chr17_-_34862122 | 4.23 |
ENSMUST00000154526.1
|
Cfb
|
complement factor B |
chr3_+_40846970 | 4.21 |
ENSMUST00000108078.2
|
3110057O12Rik
|
RIKEN cDNA 3110057O12 gene |
chr7_+_65862029 | 4.19 |
ENSMUST00000055576.5
ENSMUST00000098391.4 |
Pcsk6
|
proprotein convertase subtilisin/kexin type 6 |
chr7_-_30973367 | 4.17 |
ENSMUST00000108116.3
|
Lsr
|
lipolysis stimulated lipoprotein receptor |
chr10_-_75781411 | 4.16 |
ENSMUST00000001715.3
|
Gstt3
|
glutathione S-transferase, theta 3 |
chr11_+_83709015 | 4.15 |
ENSMUST00000001009.7
|
Wfdc18
|
WAP four-disulfide core domain 18 |
chr8_-_120634379 | 4.15 |
ENSMUST00000123927.1
|
1190005I06Rik
|
RIKEN cDNA 1190005I06 gene |
chr9_-_22002599 | 4.13 |
ENSMUST00000115336.2
ENSMUST00000044926.5 |
Ccdc151
|
coiled-coil domain containing 151 |
chr16_+_37580137 | 4.09 |
ENSMUST00000160847.1
|
Hgd
|
homogentisate 1, 2-dioxygenase |
chr13_+_23870284 | 4.08 |
ENSMUST00000006785.7
|
Slc17a1
|
solute carrier family 17 (sodium phosphate), member 1 |
chr12_-_103863551 | 4.08 |
ENSMUST00000085056.6
ENSMUST00000072876.5 ENSMUST00000124717.1 |
Serpina1a
|
serine (or cysteine) peptidase inhibitor, clade A, member 1A |
chr17_+_32685610 | 4.04 |
ENSMUST00000168171.1
|
Cyp4f15
|
cytochrome P450, family 4, subfamily f, polypeptide 15 |
chr11_+_48837465 | 4.04 |
ENSMUST00000046903.5
|
Trim7
|
tripartite motif-containing 7 |
chr5_-_53213447 | 4.01 |
ENSMUST00000031090.6
|
Sel1l3
|
sel-1 suppressor of lin-12-like 3 (C. elegans) |
chr18_+_51117754 | 4.00 |
ENSMUST00000116639.2
|
Prr16
|
proline rich 16 |
chr11_+_73199445 | 4.00 |
ENSMUST00000006105.6
|
Shpk
|
sedoheptulokinase |
chr3_+_60031754 | 3.99 |
ENSMUST00000029325.3
|
Aadac
|
arylacetamide deacetylase (esterase) |
chr4_-_89294608 | 3.99 |
ENSMUST00000107131.1
|
Cdkn2a
|
cyclin-dependent kinase inhibitor 2A |
chr1_+_191906743 | 3.97 |
ENSMUST00000044954.6
|
Slc30a1
|
solute carrier family 30 (zinc transporter), member 1 |
chr13_-_41847626 | 3.97 |
ENSMUST00000121404.1
|
Adtrp
|
androgen dependent TFPI regulating protein |
chr8_-_3467617 | 3.96 |
ENSMUST00000111081.3
ENSMUST00000118194.1 ENSMUST00000004686.6 |
Pex11g
|
peroxisomal biogenesis factor 11 gamma |
chr7_-_140102326 | 3.95 |
ENSMUST00000128527.1
|
Fuom
|
fucose mutarotase |
chr11_+_114851814 | 3.95 |
ENSMUST00000053361.5
ENSMUST00000021071.7 ENSMUST00000136785.1 |
Gprc5c
|
G protein-coupled receptor, family C, group 5, member C |
chr17_+_56162477 | 3.92 |
ENSMUST00000077788.6
|
Tnfaip8l1
|
tumor necrosis factor, alpha-induced protein 8-like 1 |
chr14_+_51091077 | 3.91 |
ENSMUST00000022428.5
ENSMUST00000171688.1 |
Rnase4
Ang
|
ribonuclease, RNase A family 4 angiogenin, ribonuclease, RNase A family, 5 |
chr1_+_88055377 | 3.91 |
ENSMUST00000138182.1
ENSMUST00000113142.3 |
Ugt1a10
|
UDP glycosyltransferase 1 family, polypeptide A10 |
chr8_-_3717547 | 3.90 |
ENSMUST00000058040.6
|
Gm9814
|
predicted gene 9814 |
chr6_-_85915604 | 3.90 |
ENSMUST00000174369.1
|
Cml1
|
camello-like 1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.9 | 31.7 | GO:0071718 | sodium-independent icosanoid transport(GO:0071718) |
7.9 | 31.6 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
5.6 | 16.9 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
4.4 | 13.1 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
4.2 | 21.0 | GO:0051594 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
4.1 | 12.2 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
3.9 | 11.6 | GO:0061402 | positive regulation of transcription from RNA polymerase II promoter in response to acidic pH(GO:0061402) |
3.7 | 11.2 | GO:0031335 | regulation of sulfur amino acid metabolic process(GO:0031335) |
3.4 | 10.2 | GO:0019343 | cysteine biosynthetic process via cystathionine(GO:0019343) |
3.1 | 9.4 | GO:0006533 | aspartate catabolic process(GO:0006533) |
2.9 | 8.8 | GO:2000295 | regulation of hydrogen peroxide catabolic process(GO:2000295) |
2.9 | 95.9 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
2.8 | 8.3 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
2.8 | 2.8 | GO:0009441 | glycolate metabolic process(GO:0009441) |
2.7 | 10.9 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
2.6 | 10.3 | GO:0016103 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
2.5 | 10.1 | GO:0090467 | L-arginine import(GO:0043091) arginine import(GO:0090467) |
2.5 | 7.5 | GO:0018900 | dichloromethane metabolic process(GO:0018900) chlorinated hydrocarbon metabolic process(GO:0042196) halogenated hydrocarbon metabolic process(GO:0042197) |
2.4 | 9.7 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
2.4 | 7.2 | GO:0018894 | dibenzo-p-dioxin metabolic process(GO:0018894) |
2.4 | 61.8 | GO:0035634 | response to stilbenoid(GO:0035634) |
2.3 | 13.9 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
2.3 | 9.2 | GO:0032382 | positive regulation of intracellular lipid transport(GO:0032379) positive regulation of intracellular sterol transport(GO:0032382) positive regulation of intracellular cholesterol transport(GO:0032385) lipid hydroperoxide transport(GO:1901373) |
2.2 | 6.6 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
2.1 | 6.4 | GO:0051977 | lysophospholipid transport(GO:0051977) |
2.1 | 8.3 | GO:0010901 | regulation of very-low-density lipoprotein particle remodeling(GO:0010901) |
2.1 | 10.3 | GO:0015886 | heme transport(GO:0015886) |
2.1 | 12.3 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
1.9 | 1.9 | GO:0009804 | coumarin metabolic process(GO:0009804) |
1.9 | 9.5 | GO:1904970 | brush border assembly(GO:1904970) |
1.9 | 3.8 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
1.8 | 5.5 | GO:0001970 | positive regulation of activation of membrane attack complex(GO:0001970) |
1.7 | 5.2 | GO:1901377 | mycotoxin metabolic process(GO:0043385) mycotoxin catabolic process(GO:0043387) aflatoxin metabolic process(GO:0046222) aflatoxin catabolic process(GO:0046223) organic heteropentacyclic compound metabolic process(GO:1901376) organic heteropentacyclic compound catabolic process(GO:1901377) |
1.7 | 5.2 | GO:0042853 | glycine biosynthetic process, by transamination of glyoxylate(GO:0019265) L-alanine catabolic process(GO:0042853) |
1.7 | 8.5 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
1.7 | 26.8 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
1.6 | 4.8 | GO:0009407 | toxin catabolic process(GO:0009407) secondary metabolite catabolic process(GO:0090487) |
1.6 | 1.6 | GO:0006551 | leucine metabolic process(GO:0006551) |
1.6 | 4.8 | GO:0071579 | regulation of zinc ion transport(GO:0071579) |
1.6 | 26.9 | GO:0052695 | cellular glucuronidation(GO:0052695) |
1.5 | 4.6 | GO:0006601 | creatine biosynthetic process(GO:0006601) |
1.5 | 6.2 | GO:1903384 | neuron intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036482) positive regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902958) regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway(GO:1903383) negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway(GO:1903384) |
1.5 | 15.2 | GO:0009404 | toxin metabolic process(GO:0009404) |
1.5 | 7.5 | GO:0032902 | nerve growth factor production(GO:0032902) |
1.5 | 20.6 | GO:0015747 | urate transport(GO:0015747) |
1.5 | 4.4 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
1.5 | 2.9 | GO:1902022 | L-lysine transport(GO:1902022) |
1.4 | 4.3 | GO:0071492 | cellular response to UV-A(GO:0071492) |
1.4 | 51.1 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
1.3 | 4.0 | GO:0035962 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
1.3 | 15.6 | GO:0032782 | bile acid secretion(GO:0032782) |
1.3 | 3.8 | GO:0042339 | keratan sulfate metabolic process(GO:0042339) |
1.3 | 6.3 | GO:0036115 | fatty-acyl-CoA catabolic process(GO:0036115) |
1.2 | 3.7 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
1.2 | 7.4 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
1.2 | 3.7 | GO:1901052 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
1.2 | 12.3 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
1.2 | 8.5 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
1.2 | 9.5 | GO:0006004 | fucose metabolic process(GO:0006004) |
1.2 | 10.6 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
1.2 | 4.6 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
1.2 | 1.2 | GO:0060846 | arterial endothelial cell fate commitment(GO:0060844) blood vessel endothelial cell fate commitment(GO:0060846) Notch signaling pathway involved in arterial endothelial cell fate commitment(GO:0060853) blood vessel endothelial cell fate specification(GO:0097101) |
1.2 | 9.2 | GO:0001766 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
1.1 | 1.1 | GO:0045608 | negative regulation of auditory receptor cell differentiation(GO:0045608) |
1.1 | 2.3 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
1.1 | 5.7 | GO:0008295 | spermidine biosynthetic process(GO:0008295) putrescine biosynthetic process(GO:0009446) |
1.1 | 5.6 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
1.1 | 4.4 | GO:0002434 | immune complex clearance(GO:0002434) |
1.1 | 3.3 | GO:0042823 | pyridoxal phosphate biosynthetic process(GO:0042823) |
1.1 | 6.5 | GO:0071267 | amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
1.1 | 13.0 | GO:0046415 | urate metabolic process(GO:0046415) |
1.1 | 1.1 | GO:1902730 | positive regulation of proteoglycan biosynthetic process(GO:1902730) |
1.1 | 3.2 | GO:1904933 | regulation of cell proliferation in midbrain(GO:1904933) |
1.1 | 8.5 | GO:0097460 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
1.1 | 6.3 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
1.1 | 3.2 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
1.0 | 5.0 | GO:0006548 | histidine catabolic process(GO:0006548) |
1.0 | 4.0 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
1.0 | 9.8 | GO:0051596 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
1.0 | 1.9 | GO:1904580 | regulation of intracellular mRNA localization(GO:1904580) |
1.0 | 15.2 | GO:0017144 | drug metabolic process(GO:0017144) |
0.9 | 8.4 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
0.9 | 4.7 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.9 | 1.9 | GO:0032242 | regulation of nucleoside transport(GO:0032242) |
0.9 | 5.6 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.9 | 2.8 | GO:1990166 | protein localization to site of double-strand break(GO:1990166) |
0.9 | 3.7 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
0.9 | 2.7 | GO:0010641 | positive regulation of platelet-derived growth factor receptor signaling pathway(GO:0010641) |
0.9 | 3.6 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.9 | 2.7 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.9 | 3.6 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.9 | 4.5 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
0.9 | 5.3 | GO:0045905 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
0.9 | 6.2 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.9 | 14.9 | GO:0060363 | cranial suture morphogenesis(GO:0060363) |
0.9 | 6.1 | GO:1904217 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.9 | 1.7 | GO:1903719 | regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
0.9 | 2.6 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.9 | 3.4 | GO:0046294 | formaldehyde catabolic process(GO:0046294) |
0.8 | 4.1 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.8 | 0.8 | GO:2000451 | positive regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000451) |
0.8 | 2.4 | GO:0010716 | negative regulation of extracellular matrix disassembly(GO:0010716) |
0.8 | 4.9 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.8 | 4.8 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
0.8 | 3.2 | GO:2000256 | positive regulation of male germ cell proliferation(GO:2000256) |
0.8 | 4.8 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.8 | 3.1 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.8 | 3.9 | GO:0032430 | positive regulation of phospholipase A2 activity(GO:0032430) |
0.8 | 3.1 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.8 | 3.8 | GO:0015788 | UDP-N-acetylglucosamine transport(GO:0015788) |
0.8 | 3.8 | GO:0033499 | galactose catabolic process via UDP-galactose(GO:0033499) |
0.8 | 5.3 | GO:0006108 | malate metabolic process(GO:0006108) |
0.8 | 3.0 | GO:0099527 | postsynapse to nucleus signaling pathway(GO:0099527) |
0.8 | 3.8 | GO:0070602 | regulation of centromeric sister chromatid cohesion(GO:0070602) |
0.8 | 12.1 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.7 | 9.0 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.7 | 3.6 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.7 | 5.7 | GO:0009137 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
0.7 | 4.3 | GO:0034214 | protein hexamerization(GO:0034214) |
0.7 | 3.4 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
0.7 | 4.1 | GO:0010730 | negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
0.7 | 2.0 | GO:0034959 | substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
0.7 | 2.7 | GO:0030070 | insulin processing(GO:0030070) |
0.7 | 2.0 | GO:0051030 | RNA import into nucleus(GO:0006404) snRNA transport(GO:0051030) |
0.7 | 7.3 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.7 | 4.0 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.7 | 1.3 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.6 | 1.9 | GO:0010512 | negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) |
0.6 | 2.6 | GO:0009115 | xanthine catabolic process(GO:0009115) |
0.6 | 5.7 | GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
0.6 | 6.3 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
0.6 | 3.8 | GO:0033762 | response to glucagon(GO:0033762) |
0.6 | 1.9 | GO:0048209 | regulation of vesicle targeting, to, from or within Golgi(GO:0048209) |
0.6 | 3.7 | GO:1902847 | regulation of neuronal signal transduction(GO:1902847) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
0.6 | 2.5 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.6 | 1.2 | GO:0030908 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.6 | 1.2 | GO:2000439 | positive regulation of monocyte extravasation(GO:2000439) |
0.6 | 2.4 | GO:0090126 | protein complex assembly involved in synapse maturation(GO:0090126) |
0.6 | 1.8 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
0.6 | 1.8 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.6 | 1.2 | GO:0015817 | histidine transport(GO:0015817) |
0.6 | 3.6 | GO:0039019 | pronephric nephron development(GO:0039019) |
0.6 | 2.9 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
0.6 | 7.5 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.6 | 1.7 | GO:0060785 | regulation of apoptosis involved in tissue homeostasis(GO:0060785) |
0.6 | 1.7 | GO:0045074 | follicular dendritic cell activation(GO:0002266) follicular dendritic cell differentiation(GO:0002268) interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.6 | 3.9 | GO:0070189 | tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) kynurenine metabolic process(GO:0070189) |
0.6 | 5.5 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
0.5 | 2.7 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.5 | 1.6 | GO:0060490 | orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
0.5 | 4.3 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.5 | 4.3 | GO:0060332 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.5 | 6.5 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.5 | 6.4 | GO:0099638 | endosome to plasma membrane protein transport(GO:0099638) |
0.5 | 1.6 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.5 | 1.6 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.5 | 1.6 | GO:1990859 | cellular response to endothelin(GO:1990859) |
0.5 | 2.1 | GO:0072061 | inner medullary collecting duct development(GO:0072061) negative regulation of nodal signaling pathway(GO:1900108) |
0.5 | 2.1 | GO:0071798 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.5 | 2.1 | GO:1901098 | positive regulation of autophagosome maturation(GO:1901098) |
0.5 | 3.6 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
0.5 | 1.5 | GO:0010845 | positive regulation of reciprocal meiotic recombination(GO:0010845) |
0.5 | 5.6 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.5 | 2.5 | GO:0001997 | positive regulation of the force of heart contraction by epinephrine-norepinephrine(GO:0001997) positive regulation of the force of heart contraction by chemical signal(GO:0003099) |
0.5 | 1.5 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
0.5 | 4.5 | GO:0010896 | regulation of triglyceride catabolic process(GO:0010896) positive regulation of triglyceride catabolic process(GO:0010898) |
0.5 | 0.5 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.5 | 2.4 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.5 | 2.4 | GO:1900170 | negative regulation of glucocorticoid mediated signaling pathway(GO:1900170) |
0.5 | 2.4 | GO:0046967 | cytosol to ER transport(GO:0046967) |
0.5 | 1.9 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
0.5 | 1.9 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
0.5 | 1.4 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) response to fructose(GO:0009750) cellular response to fructose stimulus(GO:0071332) |
0.5 | 4.6 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.5 | 4.1 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.5 | 1.8 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.5 | 1.4 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.5 | 2.3 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.4 | 3.1 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.4 | 2.7 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.4 | 1.3 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.4 | 1.8 | GO:0006880 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
0.4 | 3.5 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.4 | 1.3 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.4 | 1.7 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.4 | 1.3 | GO:0007521 | muscle cell fate determination(GO:0007521) |
0.4 | 1.3 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.4 | 0.9 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
0.4 | 5.5 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.4 | 2.9 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.4 | 1.2 | GO:0007172 | signal complex assembly(GO:0007172) regulation of cGMP-mediated signaling(GO:0010752) regulation of B cell chemotaxis(GO:2000537) positive regulation of B cell chemotaxis(GO:2000538) |
0.4 | 2.1 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.4 | 3.3 | GO:0009435 | NAD biosynthetic process(GO:0009435) |
0.4 | 0.8 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.4 | 5.3 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.4 | 1.2 | GO:0009155 | purine deoxyribonucleotide catabolic process(GO:0009155) purine deoxyribonucleoside triphosphate catabolic process(GO:0009217) |
0.4 | 2.4 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.4 | 1.2 | GO:0071929 | alpha-tubulin acetylation(GO:0071929) |
0.4 | 2.4 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.4 | 4.0 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
0.4 | 1.2 | GO:0036500 | ATF6-mediated unfolded protein response(GO:0036500) |
0.4 | 0.4 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.4 | 1.2 | GO:0043519 | myosin II filament organization(GO:0031038) regulation of myosin II filament organization(GO:0043519) |
0.4 | 1.2 | GO:1990167 | protein K27-linked deubiquitination(GO:1990167) protein K33-linked deubiquitination(GO:1990168) |
0.4 | 0.8 | GO:0035787 | cell migration involved in kidney development(GO:0035787) |
0.4 | 2.3 | GO:0001757 | somite specification(GO:0001757) |
0.4 | 1.1 | GO:1905204 | septum secundum development(GO:0003285) cardiac muscle tissue regeneration(GO:0061026) negative regulation of connective tissue replacement(GO:1905204) |
0.4 | 1.9 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.4 | 1.1 | GO:1903294 | regulation of glutamate secretion, neurotransmission(GO:1903294) positive regulation of glutamate secretion, neurotransmission(GO:1903296) |
0.4 | 1.5 | GO:1901740 | negative regulation of myoblast fusion(GO:1901740) |
0.4 | 1.9 | GO:2000667 | positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
0.4 | 2.2 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.4 | 1.5 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.4 | 5.5 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.4 | 4.0 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.4 | 1.5 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) nucleotide-sugar catabolic process(GO:0009227) |
0.4 | 0.7 | GO:0003220 | left ventricular cardiac muscle tissue morphogenesis(GO:0003220) |
0.4 | 2.9 | GO:0015671 | oxygen transport(GO:0015671) |
0.4 | 1.4 | GO:2000384 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.4 | 6.4 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.4 | 2.1 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.3 | 2.1 | GO:0035864 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.3 | 3.1 | GO:0060633 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) |
0.3 | 0.7 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.3 | 1.3 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.3 | 1.0 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.3 | 1.0 | GO:0071651 | positive regulation of chemokine (C-C motif) ligand 5 production(GO:0071651) |
0.3 | 2.3 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) |
0.3 | 2.7 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.3 | 13.6 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.3 | 3.3 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.3 | 2.6 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.3 | 2.6 | GO:0090166 | Golgi disassembly(GO:0090166) |
0.3 | 13.8 | GO:0006953 | acute-phase response(GO:0006953) |
0.3 | 2.6 | GO:0019695 | choline metabolic process(GO:0019695) |
0.3 | 1.0 | GO:0048619 | embryonic hindgut morphogenesis(GO:0048619) |
0.3 | 2.3 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.3 | 1.0 | GO:0043181 | vacuolar sequestering(GO:0043181) |
0.3 | 1.0 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.3 | 1.0 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.3 | 4.4 | GO:0002934 | desmosome organization(GO:0002934) |
0.3 | 15.2 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.3 | 2.5 | GO:0015781 | pyrimidine nucleotide-sugar transport(GO:0015781) |
0.3 | 0.6 | GO:0046618 | drug export(GO:0046618) |
0.3 | 2.5 | GO:0045713 | low-density lipoprotein particle receptor biosynthetic process(GO:0045713) regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045714) |
0.3 | 1.6 | GO:0030638 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.3 | 0.9 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.3 | 0.9 | GO:0072014 | proximal tubule development(GO:0072014) |
0.3 | 0.6 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.3 | 2.4 | GO:0071684 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.3 | 1.8 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.3 | 0.9 | GO:0060594 | mammary gland specification(GO:0060594) |
0.3 | 0.9 | GO:0010841 | positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) |
0.3 | 2.7 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.3 | 1.2 | GO:0034769 | basement membrane disassembly(GO:0034769) |
0.3 | 2.1 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.3 | 1.8 | GO:0009249 | protein lipoylation(GO:0009249) |
0.3 | 6.5 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.3 | 2.0 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.3 | 4.6 | GO:0016264 | gap junction assembly(GO:0016264) |
0.3 | 3.1 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.3 | 6.0 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.3 | 0.9 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.3 | 1.1 | GO:1903028 | regulation of opsonization(GO:1903027) positive regulation of opsonization(GO:1903028) |
0.3 | 0.8 | GO:0048698 | negative regulation of collateral sprouting in absence of injury(GO:0048698) |
0.3 | 2.3 | GO:0006901 | vesicle coating(GO:0006901) |
0.3 | 0.8 | GO:1904954 | Spemann organizer formation(GO:0060061) canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation(GO:1904954) |
0.3 | 0.8 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
0.3 | 3.3 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.3 | 1.1 | GO:0015744 | succinate transport(GO:0015744) |
0.3 | 1.9 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.3 | 3.0 | GO:0097264 | self proteolysis(GO:0097264) |
0.3 | 1.6 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.3 | 1.6 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.3 | 1.6 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.3 | 10.4 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.3 | 0.8 | GO:0033577 | protein glycosylation in endoplasmic reticulum(GO:0033577) |
0.3 | 2.7 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.3 | 1.6 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.3 | 0.8 | GO:0050973 | detection of mechanical stimulus involved in equilibrioception(GO:0050973) |
0.3 | 0.5 | GO:0060847 | endothelial cell fate specification(GO:0060847) |
0.3 | 0.8 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.3 | 4.5 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.3 | 3.6 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.3 | 5.9 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.3 | 0.5 | GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.3 | 0.5 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.3 | 0.8 | GO:0071499 | response to laminar fluid shear stress(GO:0034616) cellular response to laminar fluid shear stress(GO:0071499) |
0.3 | 5.5 | GO:0014823 | response to activity(GO:0014823) |
0.2 | 3.7 | GO:0098792 | xenophagy(GO:0098792) |
0.2 | 0.7 | GO:0072733 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
0.2 | 1.0 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
0.2 | 0.7 | GO:0046459 | short-chain fatty acid metabolic process(GO:0046459) |
0.2 | 0.5 | GO:0032364 | oxygen homeostasis(GO:0032364) |
0.2 | 1.0 | GO:0030091 | protein repair(GO:0030091) |
0.2 | 0.7 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.2 | 0.7 | GO:0002879 | acute inflammatory response to non-antigenic stimulus(GO:0002525) regulation of acute inflammatory response to non-antigenic stimulus(GO:0002877) positive regulation of acute inflammatory response to non-antigenic stimulus(GO:0002879) |
0.2 | 0.7 | GO:0046337 | phosphatidylethanolamine metabolic process(GO:0046337) |
0.2 | 5.7 | GO:0001523 | retinoid metabolic process(GO:0001523) |
0.2 | 1.4 | GO:0009240 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate metabolic process(GO:0046490) |
0.2 | 1.4 | GO:1901673 | regulation of mitotic spindle assembly(GO:1901673) |
0.2 | 0.7 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.2 | 0.7 | GO:0021934 | hindbrain tangential cell migration(GO:0021934) |
0.2 | 0.7 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
0.2 | 1.6 | GO:0071321 | cellular response to cGMP(GO:0071321) |
0.2 | 1.1 | GO:0035376 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
0.2 | 2.9 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
0.2 | 0.7 | GO:0099542 | trans-synaptic signaling by lipid(GO:0099541) trans-synaptic signaling by endocannabinoid(GO:0099542) trans-synaptic signaling by lipid, modulating synaptic transmission(GO:0099552) trans-synaptic signaling by endocannabinoid, modulating synaptic transmission(GO:0099553) |
0.2 | 1.5 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.2 | 4.2 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.2 | 3.3 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.2 | 2.4 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.2 | 1.3 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.2 | 3.2 | GO:0016322 | neuron remodeling(GO:0016322) |
0.2 | 0.6 | GO:0021634 | optic nerve formation(GO:0021634) optic chiasma development(GO:0061360) regulation of optic nerve formation(GO:2000595) positive regulation of optic nerve formation(GO:2000597) |
0.2 | 0.9 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.2 | 1.1 | GO:1902412 | regulation of mitotic cytokinesis(GO:1902412) |
0.2 | 0.6 | GO:0044878 | mitotic cytokinesis checkpoint(GO:0044878) |
0.2 | 13.1 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.2 | 1.3 | GO:0060268 | negative regulation of respiratory burst(GO:0060268) |
0.2 | 0.6 | GO:1900477 | negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter(GO:1900477) |
0.2 | 1.6 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
0.2 | 1.2 | GO:0061042 | vascular wound healing(GO:0061042) |
0.2 | 1.0 | GO:0045925 | sperm ejaculation(GO:0042713) positive regulation of female receptivity(GO:0045925) |
0.2 | 2.7 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.2 | 0.6 | GO:0021526 | medial motor column neuron differentiation(GO:0021526) |
0.2 | 1.8 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.2 | 0.4 | GO:0070447 | positive regulation of oligodendrocyte progenitor proliferation(GO:0070447) |
0.2 | 0.8 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.2 | 0.8 | GO:0006244 | pyrimidine nucleotide catabolic process(GO:0006244) pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.2 | 2.8 | GO:0051608 | histamine transport(GO:0051608) |
0.2 | 2.2 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.2 | 1.4 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.2 | 2.0 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.2 | 1.0 | GO:0000237 | leptotene(GO:0000237) |
0.2 | 0.8 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.2 | 0.6 | GO:1904719 | excitatory chemical synaptic transmission(GO:0098976) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
0.2 | 3.7 | GO:0006692 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.2 | 5.5 | GO:0010866 | regulation of triglyceride biosynthetic process(GO:0010866) |
0.2 | 0.6 | GO:0046168 | glycerol-3-phosphate catabolic process(GO:0046168) |
0.2 | 4.7 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.2 | 1.4 | GO:0015862 | uridine transport(GO:0015862) |
0.2 | 1.0 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
0.2 | 1.0 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.2 | 2.5 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
0.2 | 3.1 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
0.2 | 1.7 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.2 | 1.1 | GO:0002084 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.2 | 3.0 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.2 | 1.3 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.2 | 0.6 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.2 | 1.9 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.2 | 0.7 | GO:0015889 | cobalamin transport(GO:0015889) |
0.2 | 0.6 | GO:0015819 | lysine transport(GO:0015819) |
0.2 | 1.1 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.2 | 2.6 | GO:0009062 | fatty acid catabolic process(GO:0009062) |
0.2 | 1.1 | GO:0048102 | autophagic cell death(GO:0048102) |
0.2 | 1.2 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
0.2 | 0.7 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.2 | 0.7 | GO:0042761 | very long-chain fatty acid biosynthetic process(GO:0042761) |
0.2 | 0.5 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.2 | 2.5 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.2 | 1.4 | GO:1990035 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
0.2 | 0.5 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.2 | 1.0 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
0.2 | 10.0 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.2 | 4.8 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.2 | 0.7 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.2 | 2.1 | GO:0006968 | cellular defense response(GO:0006968) |
0.2 | 2.0 | GO:0051132 | NK T cell activation(GO:0051132) |
0.2 | 1.5 | GO:0009301 | snRNA transcription(GO:0009301) |
0.2 | 5.8 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
0.2 | 1.5 | GO:0051798 | positive regulation of hair follicle development(GO:0051798) |
0.2 | 0.5 | GO:0015881 | creatine transport(GO:0015881) |
0.2 | 1.3 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.2 | 0.8 | GO:1990564 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.2 | 1.3 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.2 | 2.1 | GO:0010642 | negative regulation of platelet-derived growth factor receptor signaling pathway(GO:0010642) |
0.2 | 1.0 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.2 | 0.8 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) |
0.2 | 1.1 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.2 | 0.3 | GO:0060605 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.2 | 1.1 | GO:0030242 | pexophagy(GO:0030242) |
0.2 | 10.0 | GO:1902600 | hydrogen ion transmembrane transport(GO:1902600) |
0.2 | 0.5 | GO:1902037 | negative regulation of hematopoietic stem cell differentiation(GO:1902037) |
0.2 | 2.1 | GO:0042407 | cristae formation(GO:0042407) |
0.2 | 1.3 | GO:0015669 | gas transport(GO:0015669) |
0.2 | 0.5 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.2 | 1.1 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.2 | 0.8 | GO:0072092 | ureteric bud invasion(GO:0072092) |
0.2 | 0.8 | GO:2000525 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.2 | 1.1 | GO:0072086 | specification of loop of Henle identity(GO:0072086) |
0.2 | 0.5 | GO:0000239 | pachytene(GO:0000239) |
0.2 | 1.4 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.1 | 0.4 | GO:0010513 | phospholipase C-activating serotonin receptor signaling pathway(GO:0007208) regulation of phosphatidylinositol biosynthetic process(GO:0010511) positive regulation of phosphatidylinositol biosynthetic process(GO:0010513) |
0.1 | 1.9 | GO:0006465 | signal peptide processing(GO:0006465) |
0.1 | 0.3 | GO:0002475 | antigen processing and presentation via MHC class Ib(GO:0002475) |
0.1 | 0.3 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
0.1 | 0.1 | GO:0019448 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
0.1 | 2.5 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.1 | 0.4 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.1 | 0.4 | GO:1900110 | negative regulation of histone H3-K9 dimethylation(GO:1900110) regulation of glucose mediated signaling pathway(GO:1902659) positive regulation of glucose mediated signaling pathway(GO:1902661) |
0.1 | 6.8 | GO:0006637 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
0.1 | 1.3 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
0.1 | 0.9 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.1 | 0.9 | GO:0002325 | natural killer cell differentiation involved in immune response(GO:0002325) regulation of natural killer cell differentiation involved in immune response(GO:0032826) |
0.1 | 0.4 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.1 | 1.1 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.1 | 1.0 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.1 | 0.7 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.1 | 0.4 | GO:0090649 | cellular response to manganese ion(GO:0071287) response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
0.1 | 2.6 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.1 | 0.4 | GO:0003273 | cell migration involved in endocardial cushion formation(GO:0003273) |
0.1 | 5.0 | GO:1900047 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
0.1 | 1.2 | GO:0031639 | plasminogen activation(GO:0031639) |
0.1 | 0.5 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.1 | 1.9 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.1 | 0.5 | GO:0035106 | operant conditioning(GO:0035106) |
0.1 | 1.4 | GO:2000191 | regulation of fatty acid transport(GO:2000191) |
0.1 | 0.4 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.1 | 1.9 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.1 | 0.5 | GO:0072321 | protein import into mitochondrial inner membrane(GO:0045039) chaperone-mediated protein transport(GO:0072321) |
0.1 | 4.3 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.1 | 0.5 | GO:0055064 | cellular chloride ion homeostasis(GO:0030644) chloride ion homeostasis(GO:0055064) |
0.1 | 0.8 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
0.1 | 1.9 | GO:0046697 | decidualization(GO:0046697) |
0.1 | 1.1 | GO:0042996 | regulation of Golgi to plasma membrane protein transport(GO:0042996) regulation of establishment of protein localization to plasma membrane(GO:0090003) |
0.1 | 0.8 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
0.1 | 0.8 | GO:0003383 | apical constriction(GO:0003383) |
0.1 | 0.5 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.1 | 0.9 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.1 | 6.5 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.1 | 0.1 | GO:1902807 | negative regulation of cell cycle G1/S phase transition(GO:1902807) |
0.1 | 1.9 | GO:0021940 | positive regulation of cerebellar granule cell precursor proliferation(GO:0021940) |
0.1 | 3.8 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.1 | 1.0 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.1 | 0.8 | GO:0051799 | negative regulation of hair follicle development(GO:0051799) |
0.1 | 1.1 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.1 | 0.9 | GO:0021521 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.1 | 0.5 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.1 | 0.2 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.1 | 0.4 | GO:0060854 | patterning of lymph vessels(GO:0060854) |
0.1 | 0.6 | GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
0.1 | 1.4 | GO:0032933 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.1 | 1.5 | GO:0003334 | keratinocyte development(GO:0003334) |
0.1 | 0.4 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.1 | 2.7 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.1 | 1.9 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.1 | 1.6 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.1 | 0.6 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
0.1 | 0.3 | GO:0052042 | induction of programmed cell death(GO:0012502) positive regulation of apoptotic process in other organism(GO:0044533) positive regulation by symbiont of host programmed cell death(GO:0052042) positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052330) positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052501) |
0.1 | 1.0 | GO:0072017 | distal tubule development(GO:0072017) |
0.1 | 1.7 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) lobar bronchus development(GO:0060482) |
0.1 | 0.1 | GO:0046544 | development of secondary male sexual characteristics(GO:0046544) |
0.1 | 1.4 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.1 | 0.9 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.1 | 1.2 | GO:0032119 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.1 | 0.5 | GO:0007525 | somatic muscle development(GO:0007525) |
0.1 | 0.7 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
0.1 | 0.3 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.1 | 0.2 | GO:0034085 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.1 | 0.8 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.1 | 0.9 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.1 | 0.7 | GO:0045779 | negative regulation of bone resorption(GO:0045779) |
0.1 | 2.1 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 2.9 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.1 | 1.1 | GO:0080009 | mRNA methylation(GO:0080009) |
0.1 | 2.0 | GO:0099517 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.1 | 0.9 | GO:0021554 | optic nerve development(GO:0021554) |
0.1 | 0.9 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.1 | 0.6 | GO:1901911 | diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
0.1 | 0.4 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.1 | 2.6 | GO:0014898 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle hypertrophy in response to stress(GO:0014898) |
0.1 | 0.2 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.1 | 0.7 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.1 | 0.9 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.1 | 0.7 | GO:0035280 | miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) |
0.1 | 6.2 | GO:0048663 | neuron fate commitment(GO:0048663) |
0.1 | 0.4 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.1 | 1.2 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.1 | 3.7 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.1 | 0.3 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.1 | 0.3 | GO:1903630 | regulation of aminoacyl-tRNA ligase activity(GO:1903630) positive regulation of aminoacyl-tRNA ligase activity(GO:1903632) |
0.1 | 1.7 | GO:0006687 | glycosphingolipid metabolic process(GO:0006687) |
0.1 | 0.4 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.1 | 0.4 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.1 | 0.6 | GO:0007000 | nucleolus organization(GO:0007000) |
0.1 | 0.4 | GO:0051715 | cytolysis in other organism(GO:0051715) |
0.1 | 0.4 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
0.1 | 1.3 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.1 | 0.7 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.1 | 0.4 | GO:1902166 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
0.1 | 4.3 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.1 | 0.4 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
0.1 | 2.9 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.1 | 0.5 | GO:0015919 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.1 | 0.2 | GO:0019062 | virion attachment to host cell(GO:0019062) adhesion of symbiont to host cell(GO:0044650) receptor-mediated virion attachment to host cell(GO:0046813) |
0.1 | 0.5 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.1 | 0.3 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.1 | 4.2 | GO:0050907 | detection of chemical stimulus involved in sensory perception(GO:0050907) |
0.1 | 0.5 | GO:0002829 | negative regulation of type 2 immune response(GO:0002829) |
0.1 | 3.2 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.1 | 0.2 | GO:0043396 | corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) positive regulation of isotype switching to IgE isotypes(GO:0048295) positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
0.1 | 1.2 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.1 | 2.1 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.1 | 0.7 | GO:0055098 | response to low-density lipoprotein particle(GO:0055098) |
0.1 | 0.2 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.1 | 0.4 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.1 | 0.7 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.1 | 0.4 | GO:0061084 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) negative regulation of protein folding(GO:1903333) |
0.1 | 2.9 | GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
0.1 | 1.4 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.1 | 0.6 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.1 | 0.4 | GO:0016093 | polyprenol metabolic process(GO:0016093) |
0.1 | 0.3 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.1 | 1.0 | GO:0016926 | protein desumoylation(GO:0016926) |
0.1 | 0.6 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.1 | 0.4 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.1 | 1.8 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.1 | 0.7 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.1 | 5.5 | GO:1903955 | positive regulation of protein targeting to mitochondrion(GO:1903955) |
0.1 | 0.3 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
0.1 | 0.5 | GO:0033158 | regulation of protein import into nucleus, translocation(GO:0033158) |
0.1 | 0.5 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.1 | 0.3 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.1 | 0.7 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.1 | 0.4 | GO:0007210 | adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) serotonin receptor signaling pathway(GO:0007210) |
0.1 | 1.1 | GO:0010960 | magnesium ion homeostasis(GO:0010960) |
0.1 | 1.2 | GO:0031116 | positive regulation of microtubule polymerization(GO:0031116) |
0.1 | 2.1 | GO:0080171 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.1 | 0.7 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.1 | 0.5 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.1 | 0.4 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.1 | 1.0 | GO:0033753 | ribosomal subunit export from nucleus(GO:0000054) ribosome localization(GO:0033750) establishment of ribosome localization(GO:0033753) |
0.1 | 0.3 | GO:0089700 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) protein kinase D signaling(GO:0089700) |
0.1 | 0.3 | GO:0090669 | telomerase RNA stabilization(GO:0090669) |
0.1 | 0.6 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.1 | 2.0 | GO:0061036 | positive regulation of cartilage development(GO:0061036) |
0.1 | 0.8 | GO:0043981 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.1 | 1.3 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.1 | 0.2 | GO:0048338 | neural plate mediolateral regionalization(GO:0021998) mesoderm structural organization(GO:0048338) paraxial mesoderm structural organization(GO:0048352) positive regulation of cardiac ventricle development(GO:1904414) |
0.1 | 0.3 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.1 | 1.7 | GO:0048240 | sperm capacitation(GO:0048240) |
0.1 | 0.7 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.1 | 1.5 | GO:0044550 | secondary metabolite biosynthetic process(GO:0044550) |
0.1 | 2.1 |